Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Lim HM et al. | 2021 | intact cell/cell culture, human dental pulp stem cells | magnetic field, signals/pulses, low frequency, 50/60 Hz | 10 mT |
| Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
| Colciago A et al. | 2021 | intact cell/cell culture, HEI-193 cells (human vestibular schwannoma cell line derived from a NF2 patient) | 50/60 Hz, magnetic field | 0.1 T |
| Jedrzejczak-Silicka M et al. | 2021 | intact cell/cell culture, L929 cells (murine fibroblast cells) and HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz, low frequency | 5.9–28.4 mT |
| Mansoury F et al. | 2021 | intact cell/cell culture | magnetic field, low frequency, 50/60 Hz | 0.25–2 mT |
| Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
| Asadian N et al. | 2021 | intact cell/cell culture, rat bone marrow-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 400 µT |
| Dehghani-Soltani S et al. | 2021 | intact cell/cell culture, A172 (human glioblastoma cells) and T98 cell line | magnetic field, 50/60 Hz, signals/pulses, co-exposure, also other exposures without EMF | 7 mT |
| Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
| Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
